Proteomic and Bioinformatic Studies for the Characterization of Response to Pemetrexed in Platinum Drug Resistant Ovarian Cancer
Proteomics and bioinformatics are a useful combined technology for the characterization of protein expression level and modulation associated with the response to a drug and with its mechanism of action. The folate pathway represents an important target in the anticancer drugs therapy. In the presen...
Saved in:
Main Authors: | Leda Severi (Author), Lorena Losi (Author), Sergio Fonda (Author), Laura Taddia (Author), Gaia Gozzi (Author), Gaetano Marverti (Author), Fulvio Magni (Author), Clizia Chinello (Author), Martina Stella (Author), Jalid Sheouli (Author), Elena I. Braicu (Author), Filippo Genovese (Author), Angela Lauriola (Author), Chiara Marraccini (Author), Alessandra Gualandi (Author), Domenico D'Arca (Author), Stefania Ferrari (Author), Maria P. Costi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines
by: Lorena Losi, et al.
Published: (2019) -
Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library
by: Angela Lauriola, et al.
Published: (2022) -
Pemetrexed-Platinum With or Without Bevacizumab for Chinese Chemo-Naive Advanced Lung Adenocarcinoma Patients: A Real-World Study
by: Xin Li, et al.
Published: (2021) -
Efficacy and Safety of Different Doses of Bevacizumab Combined With Pemetrexed and Platinum in First-Line Treatment of Advanced NSCLC: A Retrospective-Real World Study
by: Chun-Hua Zhou, et al.
Published: (2021) -
Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy
by: Jyoti Bhagatram Sharma, et al.
Published: (2021)